Cargando…

293. Influence of a Pharmacist Led Treatment Algorithm for the Management of Staphylococcus Bacteremia

BACKGROUND: Staphylococcus bacteremia is a major healthcare burden and currently there is no widely recommended treatment algorithm. Our institution adopts all elements of antimicrobial stewardship including rapid diagnostic testing. Despite these efforts, management of staphylococcus bacteremia con...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lomanno, Jessica, Elarabi, Salwa, Fleisher, Jorge
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777304/ http://dx.doi.org/10.1093/ofid/ofaa439.336

Ejemplares similares

176. Impact of pharmacist electronic communication on the appropriateness of antimicrobial therapy at renewal time
por: Taqi, Ahmad, et al.
Publicado: (2020)

67. Impact of a Pharmacist-Driven Collaborative Initiative on Staphylococcus aureus Bacteremia Management
por: Kufel, Wesley D, et al.
Publicado: (2020)

117. Adjunctive Daptomycin in the Treatment of staphylococcus Aureus Bacteremia
por: Cheng, Matthew P, et al.
Publicado: (2020)

851. Compliance with Guidelines for Management of Staphylococcus aureus Bacteremia and its Effect on Mortality
por: Travez, Robert D, et al.
Publicado: (2020)

213. Assessment of Compliance with Order Set and Bundle for Management of Staphylococcus aureus Bacteremia
por: Flynn, Ryan R, et al.
Publicado: (2021)

140. Impact of Pharmacist-led Audit & Feedback on Outpatient Antibiotic Prescribing for UTIs and SSTIs
por: Choi, Patricia, et al.
Publicado: (2020)

1040. Effects of An Antimicrobial Stewardship Team-led Staphylococcus aureus Bacteremia Management Bundle: A Quasi-Experimental Study
por: Marx, Ashley H, et al.
Publicado: (2019)

292. Impact of the BACT/ALERT VIRTUO blood culture system in the management of Staphylococcus aureus bacteremia
por: Chavez, Miguel A, et al.
Publicado: (2020)

269. Clinical Characteristics and Outcomes of Persistent Staphylococcus aureus Bacteremia
por: Yang, Eunmi, et al.
Publicado: (2020)

684. Diagnostic Yield of Echocardiography in Coagulase Negative Staphylococcus Bacteremia
por: Nagarakanti, Sandhya, et al.
Publicado: (2021)

266. Ceftriaxone Versus Cefazolin for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteremia
por: Mohamed, Adham, et al.
Publicado: (2020)

263. An Evaluation of Quality Indicators for the Management of Staphylococcus aureus Bacteremia: A Nested Case-Control Study
por: Simms, Andrew, et al.
Publicado: (2020)

850. External Validation of the Methicillin-Resistant Staphylococcus aureus Bacteremia Score
por: Boyle, Ellen, et al.
Publicado: (2020)

1817. Characteristics and Outcomes in Patients with Staphylococcus lugdunensis Bacteremia Compared with Staphylococcus aureus and Staphylococcus epidermidis Bacteremia
por: Yukawa, Satomi, et al.
Publicado: (2022)

1041. Staphylococcus aureus Bacteremia Bundle Adherence Pre- and Post-Implementation of Mandatory Infectious Diseases Consultation and Antimicrobial Stewardship Pharmacist Intervention
por: Arensman, Kellie, et al.
Publicado: (2019)

1065. Evaluation of a Staphylococcus aureus Bacteremia Treatment Checklist
por: Soukup, Hailey, et al.
Publicado: (2018)

131. A Pharmacist Led Antimicrobial Stewardship Pilot at Discharge Improves Outpatient Antibiotic Utilization
por: Hiryak, Kayla, et al.
Publicado: (2021)

59. Impact of Pharmacist-Led De-Escalation of MRSA Therapy Using MRSA Nasal PCR
por: Salvatus, Marc, et al.
Publicado: (2021)

53. Effect of rapid identification of bloodstream isolates on antibiotic management using a pharmacist-based treatment algorithm
por: Marshall, Marybeth, et al.
Publicado: (2020)

697. 8 Years of Characteristics and Outcomes of Patients with MRSA Endocarditis Based on Vancomycin Minimum Inhibitory Concentration: Experience at a Tertiary Care Hospital
por: Alpizar-Rivas, Rodolfo M, et al.
Publicado: (2020)

698. 8 Years of Infective Endocarditis in Intravenous and Non-Intravenous Drug Users a Single Center Experience
por: Alpizar-Rivas, Rodolfo M, et al.
Publicado: (2020)

276. Comparison of Ceftaroline in Combination with Either Vancomycin or Daptomycin for the Treatment of Methicillin-resistant Staphylococcus aureus Bacteremia
por: Welch, Stephanie N, et al.
Publicado: (2020)

311. The Role of Transthoracic Echocardiography in Staphylococcus aureus Bacteremia; A Retrospective Chart Review
por: Aldred, Bruce M, et al.
Publicado: (2020)

42. A Pharmacist-Led Intervention to Decrease Anaerobic Coverage for Hospitalized Patients with Community-Acquired Pneumonia
por: Enzmann, Maxx O, et al.
Publicado: (2020)

Impact of a Pharmacist-Led Diabetes Management Intervention to Improve Health Equity
por: Smith-Ray, Renae, et al.
Publicado: (2021)

197. Implementation of a Prospective, Pharmacist-Led Methicillin-Resistant Staphylococcus aureus Nasal PCR Screening Pilot Protocol to Reduce Overutilization of Vancomycin
por: Miller, Jessica, et al.
Publicado: (2018)

307. Rapid Resistance Development to Three Antistaphylococcal Therapies in Daptomycin-tolerant Staphylococcus aureus Bacteremia
por: Miller, Christopher R, et al.
Publicado: (2020)

301. Penicillin Versus Cefazolin or Anti-staphylococcal Penicillins for Penicillin-Susceptible Staphylococcus aureus Bacteremia
por: Aldhaeefi, Mohammed, et al.
Publicado: (2020)

302. Peripheral IV catheters, a common source of healthcare-associated Staphylococcus aureus bacteremia
por: Young, Heather, et al.
Publicado: (2020)

264. Anti-platelet Therapy Significantly Reduces Inpatient Mortality in Patients with Staphylococcus aureus Bacteremia
por: Caffrey, Aisling, et al.
Publicado: (2020)

190. Outcomes of Early Ceftaroline-based Combination Therapy for Methicillin-resistant Staphylococcus aureus Bacteremia
por: Dolan, Mackenzie, et al.
Publicado: (2021)

187. Vancomycin Plus Ceftaroline Salvage Therapy for Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia
por: Kufel, Wesley D, et al.
Publicado: (2021)

216. Bacterial Genotype and Clinical Outcomes in Solid Organ Transplant Recipients with Staphylococcus aureus Bacteremia
por: Eichenberger, Emily, et al.
Publicado: (2021)

86. Use of a Novel Clinical Decision Support Tool for Pharmacist-Led Antimicrobial Stewardship in Patients with Normal Procalcitonin
por: Watkins, Andrew B, et al.
Publicado: (2020)

280. Description of Transesophageal Echocardiography Prescribing Practices in non-Staphylococcus aureus Bacteremia with Application of Scoring Systems
por: Luttmann, Kelly F, et al.
Publicado: (2020)

257. Staphylococcus aureus Bacteremia: Does Intravenous Drug Use Impact Quality of Care and Clinical Outcomes?
por: McClellan, Kristen, et al.
Publicado: (2020)

291. Impact of Surveillance and Offered Infectious Diseases Consults for Staphylococcus aureus Bacteremia on Quality of Care Indicators
por: Jhaveri, Khushali, et al.
Publicado: (2020)

1373. Racial Disparities in Clinical Characteristics and Outcomes for Methicillin Susceptible and Methicillin-Resistant Staphylococcus aureus Bacteremia
por: Mohnasky, Michael C, et al.
Publicado: (2021)

204. Clinical Outcomes with Ceftaroline Monotherapy versus Daptomycin-Ceftaroline Combination Therapy in the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
por: Andonie, Gabriela, et al.
Publicado: (2021)

312. Unplanned Readmission after Hospitalization with Staphylococcus aureus Bacteremia in Children: a Multistate Population Based Study
por: Inagaki, Kengo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_m38na1fvbib5mntg8ffhurll90